+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Allogeneic Cell Therapy"

From
Allogeneic Cell Therapy - Global Strategic Business Report - Product Thumbnail Image

Allogeneic Cell Therapy - Global Strategic Business Report

  • Report
  • April 2025
  • 275 Pages
  • Global
From
Allogeneic Cell Therapy Market Report 2025 - Product Thumbnail Image

Allogeneic Cell Therapy Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
Allogeneic Stem Cells - Global Strategic Business Report - Product Thumbnail Image

Allogeneic Stem Cells - Global Strategic Business Report

  • Report
  • April 2025
  • 89 Pages
  • Global
From
Stem Cell Manufacturing - Global Strategic Business Report - Product Thumbnail Image

Stem Cell Manufacturing - Global Strategic Business Report

  • Report
  • April 2025
  • 89 Pages
  • Global
From
Adult Stem Cells - Global Strategic Business Report - Product Thumbnail Image

Adult Stem Cells - Global Strategic Business Report

  • Report
  • April 2025
  • 204 Pages
  • Global
From
Cell Banking Outsourcing - Global Strategic Business Report - Product Thumbnail Image

Cell Banking Outsourcing - Global Strategic Business Report

  • Report
  • April 2025
  • 366 Pages
  • Global
From
From
Loading Indicator

Allogeneic cell therapy is a type of genomics-based therapy that uses cells from a donor to treat a patient. It is a form of immunotherapy that uses cells from a healthy donor to stimulate the patient's immune system to fight disease. Allogeneic cell therapy is used to treat a variety of conditions, including cancer, autoimmune diseases, and genetic disorders. It is also being explored as a potential treatment for neurological disorders. Allogeneic cell therapy is a rapidly growing field, with many companies developing new treatments and technologies. Examples of companies in the allogeneic cell therapy market include Kite Pharma, Juno Therapeutics, and Bellicum Pharmaceuticals. Other companies, such as Cellectis and Fate Therapeutics, are also researching and developing allogeneic cell therapies. Show Less Read more